Text Size
1 study found for:    NCT01265576

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Condition: HCC
Interventions: Drug: Sorafenib;   Drug: VT-122 (propranolol plus etodolac);   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years